Zymergen: Zymergen Gets Conditional OK For Ch. 11 Asset Sales
A Delaware bankruptcy judge on Tuesday signaled she would approve biotechnology company Zymergen's asset sales to two bidders as part of its Chapter 11 liquidation plan, under an agreement whereby the debtor's parent will acquire most of the business.
Read full article »
Zymergen is a California-based biotechnology company that designs and produces molecules, microbes and materials for agriculture, packaging and manufacturing industries.
Read more